Report cover image

Global Nucleic Acid-Based Multiplex Assays Market Growth (Status and Outlook) 2025-2031

Publisher LP Information, Inc.
Published Sep 05, 2025
Length 96 Pages
SKU # LPI20370970

Description

According to this study, the global Nucleic Acid-Based Multiplex Assays market size will reach US$ 921 million by 2031.

Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others. 

A significant driver in the Nucleic Acid-Based Multiplex Assays market is the growing demand for rapid and comprehensive diagnostics, particularly in the fields of infectious diseases and genomics research. Multiplex assays enable the simultaneous detection of multiple nucleic acid targets in a single test, offering efficiency and cost-effectiveness. However, a notable challenge in this market is the need for assay standardization and data analysis. Ensuring that multiplex assays provide consistent and reliable results across different platforms and that data interpretation remains accessible while addressing potential challenges in assay design and optimization poses a significant challenge. Manufacturers and healthcare providers must collaborate to establish standards, streamline assay workflows, and develop user-friendly data analysis tools to maximize the potential of nucleic acid-based multiplex assays in various diagnostic and research applications.

LPI (LP Information)' newest research report, the “Nucleic Acid-Based Multiplex Assays Industry Forecast” looks at past sales and reviews total world Nucleic Acid-Based Multiplex Assays sales in 2024, providing a comprehensive analysis by region and market sector of projected Nucleic Acid-Based Multiplex Assays sales for 2025 through 2031. With Nucleic Acid-Based Multiplex Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid-Based Multiplex Assays industry.

This Insight Report provides a comprehensive analysis of the global Nucleic Acid-Based Multiplex Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic Acid-Based Multiplex Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid-Based Multiplex Assays market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid-Based Multiplex Assays and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid-Based Multiplex Assays.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid-Based Multiplex Assays market by product type, application, key players and key regions and countries.

Segmentation by Type:
Reagents & Consumables
Instruments & Accessories
Software & Services

Segmentation by Application:
Companion Diagnostics
Research & Development
Clinical Diagnostics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

96 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Nucleic Acid-Based Multiplex Assays Market Size by Player
4 Nucleic Acid-Based Multiplex Assays by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Nucleic Acid-Based Multiplex Assays Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us